144 related articles for article (PubMed ID: 2737796)
1. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
Raz I; Hussein Z; Samara E; Ben-David J
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
[TBL] [Abstract][Full Text] [Related]
4. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
Hasan MM; Najib NM; Muti H
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
[TBL] [Abstract][Full Text] [Related]
5. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans.
Mascher H
Drug Des Deliv; 1989 Jun; 4(4):303-11. PubMed ID: 2775450
[TBL] [Abstract][Full Text] [Related]
9. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
Iqbal Z; Khan R; Nasir F; Khan JA; Rashid A; Khan A; Khan A
Pak J Pharm Sci; 2011 Oct; 24(4):435-43. PubMed ID: 21959802
[TBL] [Abstract][Full Text] [Related]
14. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
Walter K; von Nieciecki A
Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
[TBL] [Abstract][Full Text] [Related]
15. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
[TBL] [Abstract][Full Text] [Related]
16. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
[TBL] [Abstract][Full Text] [Related]
17. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Lissy M; Stiff DD; Kowalski MM; Moore KA
Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
[TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects.
Hasan MM; Najib NM; Rawashdeh NM; Sallam EN; Shubair MS; Alawneh Y
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):178-83. PubMed ID: 2071269
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration].
Vens-Cappell B; Hilgenstock C; Gellert M; Kühle K; Reifferscheid I; Winckler P; Bührens KG
Arzneimittelforschung; 1993 Mar; 43(3):346-50. PubMed ID: 8489566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]